Ausgabe 1/2006
Inhalt (13 Artikel)
Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer
V. Ozmen, H. Karanlik, N. Cabioglu, A. Igci, M. Kecer, O. Asoglu, S. Tuzlali, A. Mudun
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies
Michelle D. Martin, Susan G. Hilsenbeck, Syed K. Mohsin, Torsten A. Hopp, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Peter O’Connell
Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy
J.L. Grabinski, L.S. Smith, G.B. Chisholm, R. Drengler, G.I. Rodriguez, A.S. Lang, S.P. Kalter, A.M. Garner, L.M. Fichtel, J. Hollsten, B.H. Pollock, J.G. Kuhn
Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation
Joseph N. Contessa, Angela Abell, Ross B. Mikkelsen, Kristoffer Valerie, Rupert K. Schmidt-Ullrich
Breast cancer risk assessment in the Czech female population – an adjustment of the original Gail model
Jan Novotny, Ladislav Pecen, Lubos Petruzelka, Adam Svobodnik, Ladislav Dusek, Jan Danes, Miloslava Skovajsova
Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3
Sailaja Koduri, Anita S. Goldhar, Barbara K. Vonderhaar
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
M. Venturini, C. Bighin, S. Monfardini, F. Cappuzzo, N. Olmeo, A. Durando, F. Puglisi, O. Nicoletto, A. Lambiase, L. Del Mastro
A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients
Bruno Cutuli, Paul Henri Cottu, Jean Paul Guastalla, Hubert Mechin, Anne Costa, Rosemary Jourdan
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer
Karolina Przybylowska, Anita Kluczna, Marek Zadrozny, Tadeusz Krawczyk, Andrzej Kulig, Jan Rykala, Agnieszka Kolacinska, Zbigniew Morawiec, Jozef Drzewoski, Janusz Blasiak
Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer
A.M. Brewster, T.J. Jorgensen, I. Ruczinski, H.Y. Huang, S. Hoffman, L. Thuita, C. Newschaffer, R.M. Lunn, D. Bell, K.J. Helzlsouer
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations
Marcela Gallardo, Antonia Silva, Lorena Rubio, Carolina Alvarez, Carolina Torrealba, Mauricio Salinas, Teresa Tapia, Paola Faundez, Lorena Palma, María Eugenia Riccio, Hernando Paredes, Mario Rodriguez, Adolfo Cruz, Christine Rousseau, Mary Claire King, Mauricio Camus, Manuel Alvarez, Pilar Carvallo
The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida
Lydia Voti, Lisa C. Richardson, Isildinha Reis, Lora E. Fleming, Jill MacKinnon, Jan Willem W. Coebergh
Can the apparent conflicting roles of PKC δ on cell proliferation and survival be reconciled?
Emanuela Maioli, Fortino Vittoria